<DOC>
	<DOCNO>NCT00610545</DOCNO>
	<brief_summary>This study design determine use atorvastatin ( Lipitor ) , member HMG coA reductase inhibitor class drug refer statin , reduce cardiovascular outcome ( mortality - myocardial infarction - stroke ) give high dos comparative standard dos perioperative period major vascular surgery . Abdominal aortic aneurysm , Carotid endarterectomy , Revascularization low limb</brief_summary>
	<brief_title>Atorvastatin Perioperative Vascular Surgery - Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Vascular surgery ( abdominal aortic aneurysm , carotid endarterectomy , limbs revascularization ) Pregnant lactate woman Patient sensitivity atorvastatin Patient elevation certain laboratory value ( CK , AST , ALT ) Known history active hepatic disease know hepatic insufficiency Patients participate another clinical trial Prior statin therapy include : &gt; 10 mg atorvastatin ( Lipitor ) &gt; 20 mg HMGCoA Reductase Inhibitors ( statin ) use rosuvastatin Serious infectious disease surgery Known history cancer</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>ATORVASTATIN</keyword>
	<keyword>VASCULAR SURGERY</keyword>
	<keyword>CARDIOVASCULAR OUTCOMES</keyword>
</DOC>